Korrobio

Korrobio

5 open positions
Last updated Oct 2, 2026
5 employees
Remote0%
Hybrid55%
On-site45%
Salary shown100%
Avg. listing102d
This month2 new · 0 closed

Associate Director, Clinical Quality Assurance

$190k–$220k/year
73
High

The Associate Director, Clinical QA will provide hands-on quality oversight of Korro Bio's clinical and nonclinical programs, ensuring that studies are conducted, and that data is generated and reported in compliance with Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and Good Clinica

OtherQuality AssuranceFull-TimeExecutive
See 2 similar>
2 0 0 New 13h ago

Senior Scientist

$160k–$180k/year
71
High

Korro Bio is seeking an experienced Senior Scientist to lead our HTS-NGS team in support of our oligonucleotide platform and portfolio projects. This is a hybrid leadership and hands-on role that requires a combination of scientific expertise, team management, and cross-functional collaboration. The

OtherScientistFull-TimeSenior
See 2 similar>
3 0 0 New 14h ago

Associate Director, Data Manager

$185k–$220k/year
50
Low

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natu

DataData ManagerFull-TimeExecutive
See 2 similar>
1 0 0 6d ago

Senior Clinical Trial Manager

$163k–$187k/year
35
Lowest

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natu

HealthcareClinical ResearcherFull-TimeSenior
See 2 similar>
0 0 0↻ Repost 16d ago

Scientist I, Biology

$120k–$145k/year
34
Lowest

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natu

OtherScientistFull-TimeMid
See 2 similar>
1 0 0 1mo ago